BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.
Beryl Drugs Ltd: key numbers
- Share price
- ₹25.00
- Market cap
- ₹12.68 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.3×Sector 46.1×
- Promoter holding
- 27.97%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beryl Drugs Ltd
All →Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Other Announcement
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.
Beryl Drugs Annual General Meeting
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
Beryl Drugs Annual Report
Beryl Drugs Ltd has submitted its 33rd Annual Report for the financial year 2025-26, scheduled for its upcoming Annual General Meeting.
Beryl Drugs Annual General Meeting
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Board Meeting Outcome
Beryl Drugs Limited approved items for its 33rd Annual General Meeting and a proposal to increase material related party transaction limits.
Other other announcement announcements
All →Parth Electricals & Engineering Other Announcement
Parth Electricals filed its fifth Monitoring Agency Report for the quarter ended September 30, 2026. It confirms no deviation from the issue objects.
KHFM Hospitality & Facility Management Services Other Announcement
KHFM filed a non-applicability notice for the Corporate Governance Report for the quarter ended 30 September 2026, with a practising CS certificate. This is routine compliance paperwork with no business or financial event.
Motilal Oswal Financial Services Other Announcement
Motilal Oswal Financial Services certifies utilisation of proceeds from listed Commercial Papers issued in the quarter ended September 30, 2026, and adherence to listing conditions. This is a periodic regulatory compliance certificate.
Invigorated Business Consulting Other Announcement
Invigorated Business Consulting appointed GAV & Associates as statutory auditor from 1 April 2027 for 60 months. The routine appointment carries no financial impact.
- Execution
- 60 months from 1 April 2027
Boss Packaging Solutions Other Announcement
Boss Packaging Solutions Limited states that Regulation 27 corporate governance provisions do not apply to it for the quarter ended 30 September 2026, as an SME-listed company. This is a compliance non-applicability intimation with no business event.
Apar Industries Other Announcement
APAR Industries' QIP monitoring agency reported no fund deviation for the quarter ended September 30, 2026. Utilisation matches the offer document, with ₹560.14 crore unutilised.